These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1551255)

  • 1. Long-term effects on lymphocytotoxic antibodies and immune reactivity in hemodialysis patients treated with recombinant human erythropoietin.
    Bárány P; Fehrman I; Godoy C
    Clin Nephrol; 1992 Feb; 37(2):90-6. PubMed ID: 1551255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human recombinant erythropoietin therapy on panel reactive antibodies in chronic dialysis patients.
    Friedlaender MM; Azem O; Rubinger D; Brautbar C
    Isr J Med Sci; 1996 Sep; 32(9):730-6. PubMed ID: 8865827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-transfusional anti-HLA hyperimmunization: importance of erythropoietin].
    Mourad G; Chong G; Cristol JP; Lorho R; Ramounau-Pigot A; Seignalet J
    Nephrologie; 1993; 14(2):91-4. PubMed ID: 8327032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.
    Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Maiorca R
    Clin Nephrol; 1990 Dec; 34(6):272-8. PubMed ID: 2073771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL; Zezina LIu; Spudass AV
    Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that treatment of ESRD patients with recombinant human erythropoietin induces immunosuppression without affecting the distribution of peripheral blood mononuclear cell subpopulations.
    Steffensen G; Aunsholt NA; Povlsen JV
    Clin Nephrol; 1996 Feb; 45(2):98-103. PubMed ID: 8846537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
    Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
    Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
    Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
    Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
    Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
    Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients.
    Huraib S; al-Momen AK; Gader AM; Mitwalli A; Sulimani F; Abu-Aisha H
    Clin Nephrol; 1991 Nov; 36(5):252-7. PubMed ID: 1752076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreactive lymphocytotoxic IgM antibodies in highly sensitized dialysis patients waiting for a kidney transplant: identification and clinical relevance.
    Barocci S; Valente U; Gusmano R; Perfumo F; Cantarella S; Leprini A; Icardi A; Nocera A
    Clin Nephrol; 1991 Jul; 36(1):12-20. PubMed ID: 1889147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure.
    Pereira R; Costa E; Gonçalves M; Miranda V; do Sameiro Faria M; Quintanilha A; Belo L; Lima M; Santos-Silva A
    Hemodial Int; 2010 Jul; 14(3):295-301. PubMed ID: 20649681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody response to histocompatibility antigens in hemodialysis patients subjected to planned whole-blood transfusions].
    Fagiolo U; Corsano A; Antonello A; Venturi-Pasini C; Dal Lago O; Indiveri F
    Minerva Chir; 1980 May; 35(10):701-4. PubMed ID: 7005724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].
    García Martín F; Carrascosa Vallejo T; Martín Escobar E; Val Begueria J; Martín Hernández R; de Arriba G; Teno C; Salvatierra J
    Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT; Prata MM; Barbas JV; dos Santos JP
    Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M; Umezu M; Nagano M; Tagawa H
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
    Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
    Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin.
    Bárány P; Pettersson E; Konarski-Svensson JK
    Nephrol Dial Transplant; 1993; 8(5):426-32. PubMed ID: 8393547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.